Technical Analysis for ADHD - Alcobra Ltd.

Grade Last Price % Change $ Change
grade F $1.14 0.00% 0.0
ADHD closed unchanged on Monday, March 27, 2017, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ADHD trend table...

Date Alert Name Type % Chg
Mar 27 NR7 Range Contraction 0.00%
Mar 27 NR7-2 Range Contraction 0.00%
Mar 27 Narrow Range Bar Range Contraction 0.00%
Mar 27 Shooting Star Candlestick Bearish 0.00%
Mar 27 Doji - Bearish? Reversal 0.00%
Mar 27 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 24 NR7 Range Contraction 0.00%
Mar 24 Narrow Range Bar Range Contraction 0.00%
Mar 23 Stochastic Buy Signal Bullish 0.00%
Mar 22 Narrow Range Bar Range Contraction 3.64%

Older signals for ADHD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of various drugs for the treatment of neurological disturbance. Its principal product includes MG01CI that has completed Phase II studies to treat attention deficit hyperactivity disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.
Is ADHD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
Mar 16 Brosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman
Mar 15 IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
Mar 14 SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Mar 9 IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm
Mar 8 SHAREHOLDER ALERT: SFMS Announces Filing of Securities Class Action Lawsuit Against Alcobra, Ltd.
Mar 1 INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Mar 1 Alcobra to Host Investor Forum and Webcast on March 28 in New York City
Feb 24 IMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of Alcobra Ltd.
Feb 24 Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm
See more ADHD news...
Indicators
Indicator Value
52 Week High 5.75
52 Week Low 0.83
Average Volume 973,414
200-Day Moving Average 2.8651
50-Day Moving Average 1.1902
20-Day Moving Average 1.209
10-Day Moving Average 1.153
Average True Range 0.0891
ADX 9.45
+DI 25.71
-DI: 21.9
Chandelier Exit (Long, 3 ATRs) 1.1927
Chandelier Exit (Short, 3 ATRs) 1.3473
Upper Bollinger Band 1.3539
Lower Bollinger Band 1.0641
Percent B (%b) 0.26
Bandwidth 0.239702